Yolanda Cillo's Biography

Yolanda Cillo, Medical Director, Abbott Diagnostics

Dr. Cillo is a graduate of Case Western Reserve University in Cleveland Ohio with majors in Biology and English. After graduating from New Jersey Medical School in Newark, New Jersey she remained at New Jersey Medical School to complete her residency in Orthopaedic Surgery and practiced Orthopaedic Surgery for 10 years maintaining board certification in Orthopaedic Surgery. Dr. Cillo completed a Master’s in Business Administration (MBA) at the University of Redlands while in practice subsequently building a successful consulting business within the orthopaedic industry. She worked for Medtronic Spinal and Biologics with recombinant proteins for bone healing, allograft bone grafts and implantable devices for spinal surgery prior to joining Abbott in September 2007 as Medical Director for Abbott Point of Care (APOC). Currently Dr. Cillo serves as a Medical Director, Abbott Diagnostics Division (ADD) supporting APOC, ADD and Abbott Molecular.

Evolving Reimbursement Landscape’s Impact on Point-of-Care Testing

Tuesday, 29 September 2015 at 10:00

Add to Calendar ▼2015-09-29 10:00:002015-09-29 11:00:00Europe/LondonEvolving Reimbursement Landscape’s Impact on Point-of-Care TestingPoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Some insurers and reimbursement agencies regard point of care testing as a simple technology that should therefore receive less reimbursement. But not all point of care testing uses the same technology and point of care testing that does not utilize a ‘strip’ to measure values produces results comparable to the central laboratory employing complicated and advanced scientific principles and technologies. Recent changes in reimbursement for point of care testing places increasing pressure on companies to demonstrate the value of such point of care testing to justify sufficient reimbursement for these technologically advanced point of care tests. This talk will review the changes in current reimbursement status, explore how the economics of point of care testing impacts more than just the laboratory budget and discuss how outcomes and quality measures are related to the value of point of care testing.

Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health World CongressPoint-of-Care Diagnostics and Global Health World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

#POCDWC2015 Tweets

Corporate Sponsors